GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amgen Inc. (AMGN) [hlAlert]

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and
effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
( Total: 30 Current Stock Recommendations )
Amgen Inc.   (30)
Hold 47% Buy 53%
Related companies
Sanofi-aventis Sa   (17)
Hold 47% Buy 53%
Allergan, Inc.   (30)
Hold 40% Buy 60%
Novo Nordisk A/s   (18)
Sell 17% Hold 44% Buy 39%
Gilead Sciences, ...   (48)
Sell Hold 15% Buy 81%
Teva Pharmaceutical ...   (41)
Hold 27% Buy 73%
Celgene Corporation   (44)
Sell Hold Buy 84%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Filter by Gains:   
  
Rating:
Buy AMGN
up 47.61 %
Amgen Inc. (AMGN) rated Buy with price target $192 by Deutsche Bank
Thursday,  May 28, 2015  12:25 PM ET

Rating:
Buy AMGN
down 1.72 %
Amgen Inc. (AMGN) rated Buy with price target $185 by Argus
Wednesday,  Oct 29, 2014  3:25 PM ET

Rating:
Buy AMGN
up 153.94 %

Rating:
Buy AMGN
up 21.04 %
Amgen Inc. (AMGN) rated Buy with price target $140 by Argus
Monday,  Aug 4, 2014  12:00 AM ET

Rating:
Buy AMGN
up 41.87 %

Rating:
Buy AMGN
up 30.26 %
Amgen Inc. (AMGN) rated Buy with price target $135 by Argus
Friday,  Jan 31, 2014  3:25 PM ET

Rating:
Buy AMGN
up 36.16 %
Amgen Inc. (AMGN) rated Overweight by Piper Jaffray
Wednesday,  Nov 27, 2013  8:25 AM ET

Rating:
Buy AMGN
up 47.61 %
Amgen Inc. (AMGN) rated Buy with price target $142 by Deutsche Bank
Wednesday,  Nov 20, 2013  1:25 PM ET

Rating:
Buy AMGN
up 42.23 %
Amgen Inc. (AMGN) rated Buy with price target $124 by UBS
Thursday,  Aug 29, 2013  10:25 AM ET

Rating:
Buy AMGN
up 41.87 %

Rating:
Buy AMGN
up 39.73 %
Amgen Inc. (AMGN) upgraded to Overweight by Piper Jaffray
Monday,  Aug 26, 2013  8:25 AM ET

Rating:
None

Rating:
Buy AMGN
up 47.61 %
Amgen Inc. (AMGN) rated Buy with price target $115 by Deutsche Bank
Wednesday,  Apr 24, 2013  4:25 PM ET

Rating:
Hold AMGN
Amgen Inc. (AMGN) downgraded to Neutral by Piper Jaffray
Wednesday,  Apr 24, 2013  8:25 AM ET

Rating:
Buy AMGN
up 153.94 %

Your Recent Stocks
SymbolLastChange
AMGN 155.72 up  1.13 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy